Nanox AI

15/06/2026

“Osteoporosis is often silent until a fracture occurs.”

At the 251 Hellenic Air Force Hospital, Polyzois Makras, MD, Director of Dept. of Endocrinology & Diabetes and his team explored how Nanox.AI bone solution may support earlier identification of patients at risk for low bone density, using imaging data already available in routine care.

“In our pilot study with Nanox AI, we found cases of low bone density that routine practice could have missed. And this is a real game changer.”- Polyzois Makras, MD

Watch the full testimonial: https://www.youtube.com/watch?v=YdCPmjXCKLQ&t=18s

To learn more, contact us: [email protected]

10/06/2026

Bone health is already visible- but not always assessed.

Nanox.AI Bone solution: an AI-based analysis can aid identification of vertebral height loss and low bone mineral density - even when the scan wasn’t intended for osteoporosis evaluation.

Read more :https://www.nanox.vision/wp-content/uploads/2026/04/v0.3-HealthOST-WCO-poster.pdf

To learn more, contact us: [email protected]

03/06/2026

This recently published study used Nanox.AI’s cardiac solution and shows that Nanox.AI cardiac solution can aid detection of CAC in non-cardiac CT scans, including in patients who are not receiving preventive therapy.
Coronary artery calcium is a known predictor of cardiovascular events.
Read the full article:
https://www.sciencedirect.com/science/article/abs/pii/S1934592526000869

To learn more, contact us: [email protected]

02/06/2026

Exclusive distribution agreement marks Nanox’s entry into the Peruvian market.

Initial deployment is expected to include six Nanox.ARC systems under a capex model.

The agreement establishes Nanox’s presence in Peru, where access to diagnostic imaging services remains unevenly distributed across regions.

Read more in today's announcment: https://investors.nanox.vision/news-releases/news-release-details/exclusive-distribution-agreement-marks-nanoxs-entry-peruvian

27/05/2026

“What’s remarkable is how much actionable information is already there, embedded in the images, but often unutilized. That's where AI can be transformative.” - Dr. Perry Pickhardt

Professor Perry Pickhardt, MD, Professor of Radiology at the University of Wisconsin School of Medicine and Public Health and an Advisory Board member of Nanox, shares his perspective on the growing role of opportunistic screening and AI-enabled imaging insights in preventive care.

Watch the full video: https://youtu.be/71tGjzv4UZk?si=CfbPfw_r_cANLtk2

To learn more, contact us: [email protected]

Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.

20/05/2026

Many signs of cardiovascular disease already exist within routine imaging data - the challenge is identifying them early enough to act.
Nanox.AI is designed to help healthcare providers extract clinically meaningful insights from existing CT scans, supporting preventive care pathways without additional imaging.

Learn about Nanox.AI proven value: https://www.nanox.vision/ai/

Empower Medical Imaging -To Improve Patient Care. Nanox.AI lever...

04/05/2026

Nanox continues to expand its U.S. distribution network.

We’ve announced a new agreement with NuvioDx to support the deployment of Nanox.ARC systems across clinical sites in multiple states.

This collaboration reflects our approach to working with regional partners to extend access to advanced imaging and support scalable implementation in everyday care settings.

The Nanox.ARC system is an FDA-cleared multi-source digital tomosynthesis system, designed to enable 3D imaging in a broader range of clinical environments.

As we grow our channel partner ecosystem, we remain focused on connecting technology, infrastructure, and services to support more accessible imaging.

Read the full announcement: https://investors.nanox.vision/news-releases/news-release-details/nanox-announces-distribution-agreement-nuviodx-support

27/04/2026

23/04/2026

Nanox Signs Distribution Agreement with Radiology Oncology Systems to Expand Nanox.ARC Adoption in the United States.

Radiology Oncology Systems will support the commercial rollout of the Nanox.ARC, an FDA-cleared, multisource digital tomosynthesis system that makes 3D imaging possible in more clinical settings, at a lower cost and reduced radiation dose compared to traditional CT. Radiology Oncology Systems has a strong track record of supporting U.S. hospitals and clinics with reliable, cost effective technologies designed to expand access to imaging and oncology related clinical applications.

Read more: https://investors.nanox.vision/news-releases/news-release-details/nanox-signs-distribution-agreement-radiology-oncology-systems

16/04/2026

We are honored to receive this recognition from Red Dot Design Award.
Good design is fundamental to broader adoption of advanced imaging and ultimately to expanding access for the patients who need it.
The Nanox.ARC X was engineered to deliver advanced digital tomosynthesis in a single, space-efficient system that installs quickly and integrates seamlessly into clinical environments where traditional radiology equipment often cannot fit. This award reinforces our mission to expand access to essential medical imaging and improve patient outcomes.

Read the full announcement: https://www.globenewswire.com/news-release/2026/04/16/3275345/0/en/Nanox-ARC-X-Digital-Advanced-3D-imaging-built-for-access-and-powered-by-innovation-Wins-2026-Red-Dot-Award-for-Product-Design.html

TAGA Design